%0 Journal Article
%T Sofosbuvir in combination with ribavirin or simeprevir: real-life study of patients with hepatitis C genotype 4
%A Alaa Aboud
%A Amr A. Abd Elbary
%A Mohamed Abdel-Gabbar
%A Mohamed I. Zanaty
%A Mohamed Ramadan
%J Archive of "Annals of Gastroenterology".
%D 2019
%R 10.20524/aog.2018.0327
%X The discovery of direct-acting antiviral agents (DAA) is an outstanding achievement of modern medicine in the current century. The current study aimed to explore the effectiveness and safety of two regimens sofosbuvir (SOF) in combination with either ribavirin (RBV) or simeprevir (SMV) in chronic hepatitis C (CHC) genotype (GT) 4 patients in Egypt
%K Egyptian patients
%K chronic hepatitis C genotype 4
%K ribavirin
%K simeprevir
%K sofosbuvir
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302204/